FDA approves new type of non-opioid pain medication
The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...
Opinion - The FDA’s new, same-old food labels demand better obesity solutions
All things considered, it’s at least as likely to make health outcomes worse as it is to make most people healthier.
US drug regulator approves first new type of pain pill in more than 20 years
The drug offered more relief than a placebo in clinical trials, though it does not appear more effective than other pain medicines. View on euronews ...
Kennedy accused of 'misleading' vaccine arguments by Republican US senator
Robert F. Kennedy Jr, President Donald Trump's pick to run the top U.S. health agency, argued on Thursday that his ...
Pharmabiz8m
Renalys Pharma completes patient enrollment in registrational phase III trial of sparsentan for IgA nephropathy in Japan
Renalys Pharma completes patient enrollment in registrational phase III trial of sparsentan for IgA nephropathy in Japan: Tokyo, Japan Friday, January 31, 2025, 18:00 Hrs [IST] Re ...
Forbes16h
Convert Malaysian Ringgit To United States Dollar
Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances.